Literature DB >> 5157724

Comparison of the effects of drugs on the aggregation of hamster platelets in vivo and in vitro.

N A Begent, G V Born.   

Abstract

1. A method is described for measuring the inhibitory effectiveness of drugs on the aggregation by ADP of hamster platelets in vivo.2. The method was used to compare the effects of several drugs, viz. adenosine, imipramine, desmethylimipramine and aspirin, on platelet aggregation in vivo with their in vitro effects measured photometrically.3. The concentrations of adenosine and imipramine present in the cheek pouch after 10 min infusions were measured using radioactively labelled drugs.4. The results show that adenosine (0.4 muM) inhibited platelet aggregation in vivo by 43%, whereas several times this concentration was required to produce the same inhibition in vitro.5. Imipramine and desmethylimipramine (0.4 muM) did not inhibit platelet aggregation in vivo; in vitro, however, desmethylimipramine caused up to 34% inhibition at concentrations as low at 0.25 muM.6. Aspirin (estimated 0.2 mM) inhibited platelet aggregation in vivo by 37% whereas similar inhibition in vitro required about 1 mM aspirin. Sodium salicylate was several times less potent than aspirin in vivo.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5157724      PMCID: PMC1665791          DOI: 10.1111/j.1476-5381.1971.tb07188.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  20 in total

1.  STRONG INHIBITION BY 2-CHLOROADENOSINE OF THE AGGREGATION OF BLOOD PLATELETS BY ADENOSINE DIPHOSPHATE.

Authors:  G V BORN
Journal:  Nature       Date:  1964-04-04       Impact factor: 49.962

2.  Platelet clumping in vivo.

Authors:  A J HONOUR; J R MITCHELL
Journal:  Nature       Date:  1963-03-09       Impact factor: 49.962

3.  Experimental platelet embolism.

Authors:  A J HONOUR; R W RUSSELL
Journal:  Br J Exp Pathol       Date:  1962-08

4.  Enzymatic deamination and vasodepressor effects of adenosine analogs.

Authors:  D A CLARKE; J DAVOLL; F S PHILIPS; G B BROWN
Journal:  J Pharmacol Exp Ther       Date:  1952-11       Impact factor: 4.030

Review 5.  Platelet pharmacology in relation to thrombosis.

Authors:  G V Born
Journal:  Adv Cardiol       Date:  1970

6.  Inhibition of adenosine diphosphate-induced secondary aggregation and other platelet functions by acetylsalicylic acid ingestion.

Authors:  M B Zucker; J Peterson
Journal:  Proc Soc Exp Biol Med       Date:  1968-02

7.  Growth rate in vivo of platelet thrombi, produced by iontophoresis of ADP, as a function of mean blood flow velocity.

Authors:  N Begent; G V Born
Journal:  Nature       Date:  1970-08-29       Impact factor: 49.962

8.  Formation and release of prostaglandins by platelets in response to thrombin.

Authors:  J B Smith; A L Willis
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

9.  Effects of adenosine analogues and of heparin on platelet thrombi in non-lipaemic and lipaemic rats.

Authors:  G V Born; R B Philp
Journal:  Br J Exp Pathol       Date:  1965-12

10.  Enhanced adenosine inhibition of platelet aggregation in the presence of cardiac glycosides.

Authors:  F Michal; R H Thorp
Journal:  Nature       Date:  1966-01-08       Impact factor: 49.962

View more
  2 in total

1.  Antitumor effect of antiplatelet agents in gastric cancer cells: an in vivo and in vitro study.

Authors:  Jota Mikami; Yukinori Kurokawa; Tsuyoshi Takahashi; Yasuhiro Miyazaki; Makoto Yamasaki; Hiroshi Miyata; Kiyokazu Nakajima; Shuji Takiguchi; Masaki Mori; Yuichiro Doki
Journal:  Gastric Cancer       Date:  2015-10-20       Impact factor: 7.370

2.  Historical lessons in translational medicine: cyclooxygenase inhibition and P2Y12 antagonism.

Authors:  Desmond J Fitzgerald; Garret A Fitzgerald
Journal:  Circ Res       Date:  2013-01-04       Impact factor: 17.367

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.